HOLBROOK, N.Y., April 8, 2013 /PRNewswire/ -- Northstar Global Business Services, Inc. Symbol (OTCPink: MDIN), today announced that the company has released its quarterly disclosure document, which is the first that shows significant revenue in several years. The disclosure outlines sales revenue in the millions from a variety of sources including direct to consumer sales, and wholesale distribution agreements, and shows that Northstar is a viable business once again.

Since the company's fiscal year starts in September, this is actually the second quarter for Northstar in 2013, but some may argue it is the most important quarter in the company's history. Since the company re-started production of its popular anti-snoring product, Snorenz, its quarterly statements have shown no sales, and only small losses, but like a racehorse leaping out of the gates, the company went from generating nothing at all to several million dollars in sales and distribution agreements. How the products sells-through on a large scale will determine the company's long term profitability, but after a full quarter of selling products to a smaller audience through the internet and a sprinkling of retail locations, the feeling is that projections to date have been conservative. The next big growth spurt for Northstar is expected to be in June and July when major retailers re-work their shelf plans and add new products. Northstar plans to have its products in those new plans, growing from a small number of retailers and Internet sites to thousands or tens of thousands of locations globally.

Northstar's CEO, Nicholas Chieco commented, "I couldn't be prouder of what we have done here. Hard work has paid off and we can finally show all the naysayers what we are capable of. The proof is in black and white, people want our patented products, and we will work as hard as we need to in order to get them to the masses." Mr. Chieco also wants to remind everyone that while the first surge of wholesale orders consists of a larger than ordinary number of units needed to get the product initially stocked, that the company is still selling only a tiny percentage of the retail outlets possible, so there is plenty of room to grow and gain market share. Why does Snorenz command such strong consumer interest? The company maintains that since they own the patent on all natural anti-snoring spray, there is no other product like it on the market. The same holds true for the rest of the company's unique alternative healthcare products.

Anyone interested in Northstar's actual sales numbers and net profits can look at the company's second quarter 2013 disclosure on otcmarkets.com and for more information call Jennifer at 877-571-4387 or email investors@northstarbb.com

About Northstar
Northstar Global Business Services is dedicated to producing the best alternative healthcare products. The most popular products in Northstar's arsenal are Snorenz©, a patented spray for snoring relief and Stem-Intense, a unique stem cell replacement therapy supplement. Most of the company's products use a unique spray delivery system, and have received very positive consumer reviews all over the world, selling millions upon millions of units from 1996 to the present.

DISCLAIMER
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.

SOURCE Northstar Global Business Services, Inc.

Copyright 2013 PR Newswire

MedGen (CE) (USOTC:MDIN)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more MedGen (CE) Charts.
MedGen (CE) (USOTC:MDIN)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more MedGen (CE) Charts.